Printer Friendly

United States : AstraZeneca completes acquisition of rights to Actavis branded respiratory portfolio in the US and Canada.

AstraZeneca today announced that it has completed the transaction to acquire the rights to Actavis branded respiratory business in the US and Canada.

As previously announced, the strategic transaction strengthens AstraZeneca s respiratory franchise globally and builds on the acquisition of Almirall s respiratory portfolio in 2014 by extending the company s development and commercialisation rights into the US for both Tudorza Pressair and Duaklir Genuair.

AstraZeneca owns the development and commercial rights in the US and Canada to TudorzaTM PressairTM (aclidinium bromide inhalation powder), a twice-daily long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD), and to DalirespA (roflumilast), the only once-daily oral PDE4 inhibitor currently on the market for COPD, in the US. AstraZeneca also owns the development rights in the US and Canada for LAS40464, the combination of a fixed dose of aclidinium with formoterol long acting beta agonist (LAMA/LABA) in a dry powder inhaler, which is approved in the EU under the brand name DuaklirA GenuairA.

On completion of the acquisition, AstraZeneca is paying Actavis $600 million of initial consideration and agreed to pay low single-digit royalties above a certain revenue threshold. AstraZeneca has also paid Actavis an additional $100 million for a number of contractual consents and approvals, including certain amendments to the ongoing collaboration agreements between AstraZeneca and Actavis.

2015 Al Bawaba ( Provided by SyndiGate Media Inc. ( ).

COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Geographic Code:1CANA
Date:Mar 4, 2015
Previous Article:United States : ACI Worldwide and STS PayOne Partner to Provide ePayment and Fraud Prevention Services to the Middle East.
Next Article:United States : HID Global to Deliver a Secure, Mobile Access Solution via Samsung KNOX.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters